OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
September 04, 2018
Ownership of supply chain data is becoming contentious
Known as the “King of Cold Chain,” Bishara looks both back and ahead at progress in upgrading pharma’s logistics practices
Pharma supply chain managers now have options for dealing with cryogenic to room-temperature ranges
More biologic-based therapies translates into more cold chain activity. As yet, new cellular and genetic therapies are a minute part of the overall market.